A novel PGAP3 mutation in a Croatian boy with brachytelephalangy and a thin corpus callosum.

Autor: Sakaguchi T; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan., Žigman T; Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia., Petković Ramadža D; Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Omerza L; Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Pušeljić S; Department of Pediatrics, University Hospital Center Osijek, Osijek, Croatia.; School of Medicine, Osijek University, Osijek, Croatia., Ereš Hrvaćanin Z; Department of Pediatrics, General Hospital 'Dr. Josip Benčević', Slavonski Brod, Croatia., Miyake N; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan., Matsumoto N; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan., Barić I; Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia.
Jazyk: angličtina
Zdroj: Human genome variation [Hum Genome Var] 2018 Mar 08; Vol. 5, pp. 18005. Date of Electronic Publication: 2018 Mar 08 (Print Publication: 2018).
DOI: 10.1038/hgv.2018.5
Abstrakt: Biallelic mutations in the post-GPI attachment to proteins 3 ( PGAP3 ) gene cause hyperphosphatasia with mental retardation syndrome 4 (HPMRS4), which is characterized by elevated serum alkaline phosphatase, severe psychomotor developmental delay, seizures, and facial dysmorphism. To date, 15 PGAP3 mutations have been reported in humans. Here we report a novel homozygous PGAP3 mutation (c.314C>A, p.Pro105Gln) in a Croatian patient and fully describe the clinical features.
Competing Interests: The authors declare no conflict of interest.
Databáze: MEDLINE